Martyn Gross

Mr. Gross brings a diverse background in medical devices, genomics, and digital therapeutics to Mindera. Previously, Mr. Gross was President of Stratify Genomics which commercialized a genetic test for lifetime predisposition to prostate cancer. There, he brought the company from a successful IP license to revenue and important commercial partnerships. Mr. Gross previously served as the COO of Dthera Sciences, a neurodegenerative disease therapy company that was given the first FDA Breakthrough Device status for a digital therapeutic. His prior role was as the founder of Clarify Medical, a novel connected home phototherapy device used by chronic skin disease patients. Mr. Gross serves as a strategic advisor to other personalized medical startups in the San Diego area. He holds a BA in Philosophy and Religion from Azusa Pacific University and an MBA from Rady School of Management, UC San Diego.